These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 4823883)

  • 1. Determination of Arylamine N-Acetyltransferase 2 Acetylation Genotype by PCR and Phenotyping Using Dapsone Through High-Pressure Liquid Chromatography Assay: A Gender Wise Study.
    Akhter N; Iqbal T; Jamil A; Akram M; Mehmood Tahir I; Munir N
    Dose Response; 2019; 17(2):1559325819855537. PubMed ID: 31285712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone in rheumatoid arthritis.
    Kelly C; Griffiths ID
    Ann Rheum Dis; 1981 Dec; 40(6):630. PubMed ID: 7332385
    [No Abstract]   [Full Text] [Related]  

  • 3. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease and acetylation polymorphism.
    Lunde PK; Frislid K; Hansteen V
    Clin Pharmacokinet; 1977; 2(3):182-97. PubMed ID: 328206
    [No Abstract]   [Full Text] [Related]  

  • 5. The absorption of dapsone by patients with dermatitis herpetiformis and coeliac disease.
    Wright JT; Das AK
    Clin Exp Dermatol; 1980 Mar; 5(1):27-30. PubMed ID: 7398122
    [No Abstract]   [Full Text] [Related]  

  • 6. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and haemolytic effect of dapsone and its metabolites in man.
    Halmekoski J; Mattila MJ; Mustakallio KK
    Med Biol; 1978 Aug; 56(4):216-21. PubMed ID: 703406
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption and excretion of 35S dapsone in dermatitis herpetiformis.
    Alexander JO; Young E; McFadyen T; Fraser NG; Duguid WP; Meredith EM
    Br J Dermatol; 1970 Dec; 83(6):620-31. PubMed ID: 5492474
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone acetylation in dermatitis herpetiformis.
    Ellard GA; Gammon PT; Savin JA; Tan RS
    Br J Dermatol; 1974 Apr; 90(4):441-4. PubMed ID: 4823883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine points in the management of dermatitis herpetiformis.
    Fry L
    Semin Dermatol; 1988 Sep; 7(3):206-11. PubMed ID: 3153446
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.